These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 22417031)

  • 1. Unrestricted access to sugammadex: impact on neuromuscular blocking agent choice, reversal practice and associated healthcare costs.
    Ledowski T; Hillyard S; Kozman A; Johnston F; Gillies E; Greenaway M; Kyle BC
    Anaesth Intensive Care; 2012 Mar; 40(2):340-3. PubMed ID: 22417031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of unrestricted use of sugammadex on clinical anaesthetic practice in a tertiary teaching hospital.
    Watts RW; London JA; van Wijk RM; Lui YL
    Anaesth Intensive Care; 2012 Mar; 40(2):333-9. PubMed ID: 22417030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.
    Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N
    Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation.
    Paton F; Paulden M; Chambers D; Heirs M; Duffy S; Hunter JM; Sculpher M; Woolacott N
    Br J Anaesth; 2010 Nov; 105(5):558-67. PubMed ID: 20935005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
    Brueckmann B; Sasaki N; Grobara P; Li MK; Woo T; de Bie J; Maktabi M; Lee J; Kwo J; Pino R; Sabouri AS; McGovern F; Staehr-Rye AK; Eikermann M
    Br J Anaesth; 2015 Nov; 115(5):743-51. PubMed ID: 25935840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do we really need sugammadex as an antagonist of muscle relaxants in anesthesia?
    Meistelman C; Donati F
    Curr Opin Anaesthesiol; 2016 Aug; 29(4):462-7. PubMed ID: 27168088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular Blockade and Reversal Practice Variability in the Outpatient Setting: Insights From US Utilization Patterns.
    Bash LD; Black W; Turzhitsky V; Urman RD
    Anesth Analg; 2021 Dec; 133(6):1437-1450. PubMed ID: 34784330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of sugammadex on neuromuscular blocking agents use: a multicentric, pharmaco-epidemiologic study in French university hospitals and military hospitals].
    Beny K; Piriou V; Dussart C; Hénaine R; Aulagner G; Armoiry X;
    Ann Fr Anesth Reanim; 2013 Dec; 32(12):838-43. PubMed ID: 24176722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do we need to use sugammadex at the end of a general anesthesia to reverse the action of neuromuscular bloking agents? Position Paper on Sugammadex use.
    Della Rocca G; Di Marco P; Beretta L; De Gaudio AR; Ori C; Mastronardi P
    Minerva Anestesiol; 2013 Jun; 79(6):661-6. PubMed ID: 23192221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the US.
    Jiang Y; Bash LD; Saager L
    Adv Ther; 2021 May; 38(5):2689-2708. PubMed ID: 33871823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings.
    Bash LD; Turzhitsky V; Black W; Urman RD
    Adv Ther; 2021 Sep; 38(9):4736-4755. PubMed ID: 34319550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sugammadex: A Review of Neuromuscular Blockade Reversal.
    Keating GM
    Drugs; 2016 Jul; 76(10):1041-52. PubMed ID: 27324403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
    Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial.
    Putz L; Dransart C; Jamart J; Marotta ML; Delnooz G; Dubois PE
    J Clin Anesth; 2016 Dec; 35():107-113. PubMed ID: 27871505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex.
    Martinez-Ubieto J; Ortega-Lucea S; Pascual-Bellosta A; Arazo-Iglesias I; Gil-Bona J; Jimenez-Bernardó T; Muñoz-Rodriguez L
    Minerva Anestesiol; 2016 Jul; 82(7):735-42. PubMed ID: 26472231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK; Caldwell JE; Brull SJ; Soto RG
    Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neostigmine vs. sugammadex: observational cohort study comparing the quality of recovery using the Postoperative Quality Recovery Scale.
    Amorim P; Lagarto F; Gomes B; Esteves S; Bismarck J; Rodrigues N; Nogueira M
    Acta Anaesthesiol Scand; 2014 Oct; 58(9):1101-10. PubMed ID: 25179550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.